Cargando…

Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France

BACKGROUND: An outbreak of multisystem inflammatory syndrome in children, including Kawasaki disease (KD), emerged during COVID-19 pandemic. We explored whether Kawasaki-like disease (KD), when associated with confirmed SARS-CoV-2 infection, has specific characteristics. METHODS: We included childre...

Descripción completa

Detalles Bibliográficos
Autores principales: Toubiana, Julie, Cohen, Jérémie F., Brice, Joséphine, Poirault, Clément, Bajolle, Fanny, Curtis, William, Moulin, Florence, Matczak, Soraya, Leruez, Marianne, Casanova, Jean-Laurent, Chalumeau, Martin, Taylor, Melissa, Allali, Slimane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780601/
https://www.ncbi.nlm.nih.gov/pubmed/33394320
http://dx.doi.org/10.1007/s10875-020-00941-0
_version_ 1783631533628719104
author Toubiana, Julie
Cohen, Jérémie F.
Brice, Joséphine
Poirault, Clément
Bajolle, Fanny
Curtis, William
Moulin, Florence
Matczak, Soraya
Leruez, Marianne
Casanova, Jean-Laurent
Chalumeau, Martin
Taylor, Melissa
Allali, Slimane
author_facet Toubiana, Julie
Cohen, Jérémie F.
Brice, Joséphine
Poirault, Clément
Bajolle, Fanny
Curtis, William
Moulin, Florence
Matczak, Soraya
Leruez, Marianne
Casanova, Jean-Laurent
Chalumeau, Martin
Taylor, Melissa
Allali, Slimane
author_sort Toubiana, Julie
collection PubMed
description BACKGROUND: An outbreak of multisystem inflammatory syndrome in children, including Kawasaki disease (KD), emerged during COVID-19 pandemic. We explored whether Kawasaki-like disease (KD), when associated with confirmed SARS-CoV-2 infection, has specific characteristics. METHODS: We included children and adolescents with KD criteria admitted in the department of general pediatrics of a university hospital in Paris, France, between January 1, 2018, and May 26, 2020. The incidence of KD was compared between the outbreak and a pre-outbreak control period (January 1, 2018, to April 25). Characteristics of patients with positive SARS-CoV-2 testing (KD-SARS-CoV-2) were compared to those of the pre-outbreak period (classic KD). RESULTS: A total of 30 and 59 children with KD were admitted during the outbreak and pre-outbreak periods, respectively (incidence ratio 13.2 [8.3–21.0]). During the outbreak, 23/30 (77%) children were diagnosed as KD-SARS-CoV-2. When compared with patients with classic KD, those with KD-SARS-CoV-2 were more frequently of sub-Saharan African ancestry (OR 4.4 [1.6–12.6]) and older (median 8.2 vs. 4.0 years, p < 0.001), had more often initial gastrointestinal (OR 84 [4.9–1456]) and neurological (OR 7.3 [1.9–27.7] manifestations, and shock syndrome (OR 13.7 [4.2–45.1]). They had significantly higher CRP and ferritin levels. Noticeably, they had more frequently myocarditis (OR 387 [38–3933]). CONCLUSIONS: Children and adolescents with KD-SARS-CoV-2 have specific features when compared with those with classic KD. These findings should raise awareness and facilitate the study of their pathogenesis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10875-020-00941-0.
format Online
Article
Text
id pubmed-7780601
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-77806012021-01-05 Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France Toubiana, Julie Cohen, Jérémie F. Brice, Joséphine Poirault, Clément Bajolle, Fanny Curtis, William Moulin, Florence Matczak, Soraya Leruez, Marianne Casanova, Jean-Laurent Chalumeau, Martin Taylor, Melissa Allali, Slimane J Clin Immunol Original Article BACKGROUND: An outbreak of multisystem inflammatory syndrome in children, including Kawasaki disease (KD), emerged during COVID-19 pandemic. We explored whether Kawasaki-like disease (KD), when associated with confirmed SARS-CoV-2 infection, has specific characteristics. METHODS: We included children and adolescents with KD criteria admitted in the department of general pediatrics of a university hospital in Paris, France, between January 1, 2018, and May 26, 2020. The incidence of KD was compared between the outbreak and a pre-outbreak control period (January 1, 2018, to April 25). Characteristics of patients with positive SARS-CoV-2 testing (KD-SARS-CoV-2) were compared to those of the pre-outbreak period (classic KD). RESULTS: A total of 30 and 59 children with KD were admitted during the outbreak and pre-outbreak periods, respectively (incidence ratio 13.2 [8.3–21.0]). During the outbreak, 23/30 (77%) children were diagnosed as KD-SARS-CoV-2. When compared with patients with classic KD, those with KD-SARS-CoV-2 were more frequently of sub-Saharan African ancestry (OR 4.4 [1.6–12.6]) and older (median 8.2 vs. 4.0 years, p < 0.001), had more often initial gastrointestinal (OR 84 [4.9–1456]) and neurological (OR 7.3 [1.9–27.7] manifestations, and shock syndrome (OR 13.7 [4.2–45.1]). They had significantly higher CRP and ferritin levels. Noticeably, they had more frequently myocarditis (OR 387 [38–3933]). CONCLUSIONS: Children and adolescents with KD-SARS-CoV-2 have specific features when compared with those with classic KD. These findings should raise awareness and facilitate the study of their pathogenesis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10875-020-00941-0. Springer US 2021-01-04 2021 /pmc/articles/PMC7780601/ /pubmed/33394320 http://dx.doi.org/10.1007/s10875-020-00941-0 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Toubiana, Julie
Cohen, Jérémie F.
Brice, Joséphine
Poirault, Clément
Bajolle, Fanny
Curtis, William
Moulin, Florence
Matczak, Soraya
Leruez, Marianne
Casanova, Jean-Laurent
Chalumeau, Martin
Taylor, Melissa
Allali, Slimane
Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France
title Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France
title_full Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France
title_fullStr Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France
title_full_unstemmed Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France
title_short Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France
title_sort distinctive features of kawasaki disease following sars-cov-2 infection: a controlled study in paris, france
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780601/
https://www.ncbi.nlm.nih.gov/pubmed/33394320
http://dx.doi.org/10.1007/s10875-020-00941-0
work_keys_str_mv AT toubianajulie distinctivefeaturesofkawasakidiseasefollowingsarscov2infectionacontrolledstudyinparisfrance
AT cohenjeremief distinctivefeaturesofkawasakidiseasefollowingsarscov2infectionacontrolledstudyinparisfrance
AT bricejosephine distinctivefeaturesofkawasakidiseasefollowingsarscov2infectionacontrolledstudyinparisfrance
AT poiraultclement distinctivefeaturesofkawasakidiseasefollowingsarscov2infectionacontrolledstudyinparisfrance
AT bajollefanny distinctivefeaturesofkawasakidiseasefollowingsarscov2infectionacontrolledstudyinparisfrance
AT curtiswilliam distinctivefeaturesofkawasakidiseasefollowingsarscov2infectionacontrolledstudyinparisfrance
AT moulinflorence distinctivefeaturesofkawasakidiseasefollowingsarscov2infectionacontrolledstudyinparisfrance
AT matczaksoraya distinctivefeaturesofkawasakidiseasefollowingsarscov2infectionacontrolledstudyinparisfrance
AT leruezmarianne distinctivefeaturesofkawasakidiseasefollowingsarscov2infectionacontrolledstudyinparisfrance
AT casanovajeanlaurent distinctivefeaturesofkawasakidiseasefollowingsarscov2infectionacontrolledstudyinparisfrance
AT chalumeaumartin distinctivefeaturesofkawasakidiseasefollowingsarscov2infectionacontrolledstudyinparisfrance
AT taylormelissa distinctivefeaturesofkawasakidiseasefollowingsarscov2infectionacontrolledstudyinparisfrance
AT allalislimane distinctivefeaturesofkawasakidiseasefollowingsarscov2infectionacontrolledstudyinparisfrance